NEW YORK (Reuters Health) – Women who have undergone laparoscopic surgery for endometrioma have a reduced risk of recurrence when they take low-dose oral contraceptives, a Korean team…
Emru U. Seli, MD, Assistant Professor and Director of the Third Party Reproductive Program at Yale University, discusses fertility preservation for women who are about to undergo treatment…
Emru U. Seli, MD, Assistant Professor and Director of the Third Party Reproductive Program at Yale University, discusses fertility preservation for women who are about to undergo treatment…
NEW YORK (Reuters Health) – Among women undergoing resection of endometrial polyps, the prevalence of malignant or premalignant polyps ranges from about 2% to 5%, with the higher…
NEW YORK (Reuters Health) – Postmenopausal women treated for osteoporosis with the selective estrogen receptor modulator lasofoxifene have a reduced risk of coronary heart disease events, researchers report…
NEW YORK (Reuters Health) – Among women treated for endometrial hyperplasia, regression rates appear to be better with the levonorgestrel-releasing intrauterine system than with oral progestogen treatment, according…
NEW YORK (Reuters Health) – For women who have undergone laparoscopic surgery for severe endometriosis, ongoing chronic pelvic pain is relieved with use of the levonorgestrel-releasing intrauterine system…
NEW YORK (Reuters Health) – Successful outcomes of intracytoplasmic sperm injection (ICSI) are statistically the same whether the sperm used is testicular or epididymal in origin, and whether…
NEW YORK (Reuters Health) – Patients with overactive bladder (OAB) may do better with fesoterodine 8 mg/d than with tolterodine extended release 4mg/d, according to the results of…